Investors
Financials
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 15, 2026 – Q1 2026 Sales
April 22, 2026 – 2025 Annual Results
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 9, 2026 – 2025 Annual Results
April 16, 2026 – Q1 2026 Sales
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales

2024 Annual Financial Report (free translation)

Full Year 2024 Sales

Mauna Kea Technologies announces the opening of a safeguard proceeding to restructure its financial liabilities

Full Year 2024 Sales

Mauna Kea Technologies Announces its 2025 Financial Calendar

H1 2024 Financial Results and Q3 2024 Sales

Q2 2024 Sales

2023 Annual Financial Report

Full Year 2023 Results and Q1 2024 Sales

Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank

Mauna Kea Technologies Announces Initiation of Coverage by EuroLand Corporate

Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42% vs 2022
No results found.
News

Mauna Kea Technologies Announces Expanded Clinical Evidence for Cellvizio® To Be Presented at Digestive Disease Week® 2026

Mauna Kea Technologies Reports FY 2025 Financial Results: Comprehensive Debt Restructuring and Reaccelerating Organic Growth Mark a Transformative 2025

Mauna Kea Technologies Reports Strong Q1 2026 Core Sales Growth
No results found.
